Home
LLY
LLY News

Latest Eli Lilly and Company (LLY) News on July 12, 2025

MT Newswires

15 hours ago

Guggenheim Adjusts Eli Lilly and Co.'s Price Target to $942 From $936, Keeps Buy Rating

Psoriatic Arthritis Market Report 2025-2035 | Competitive Analysis of AbbVie, UCB, Pfizer, Johnson & Johnson, Eli Lilly and Co, Bristol-Myers Squibb, Affibody, Amgen, Boehringer Ingelheim, Sun Pharma

GlobeNewswire

21 hours ago

Psoriatic Arthritis Market Report 2025-2035 | Competitive Analysis of AbbVie, UCB, Pfizer, Johnson & Johnson, Eli Lilly and Co, Bristol-Myers Squibb, Affibody, Amgen, Boehringer Ingelheim, Sun Pharma

Eli Lilly Has Seized the Lead in Anti-Obesity Drugs. Next Up: a Pill.

Barrons.com

21 hours ago

Eli Lilly Has Seized the Lead in Anti-Obesity Drugs. Next Up: a Pill.

Integer Appoints Michael Coyle to Board of Directors

GlobeNewswire

a day ago

Integer Appoints Michael Coyle to Board of Directors

Verve Therapeutics, Inc. (VERV): A Bull Case Theory

Insider Monkey

a day ago

Verve Therapeutics, Inc. (VERV): A Bull Case Theory

Lilly Down More Than 15% in a Year: Time to Buy, Sell or Hold?

Zacks

2 days ago

Lilly Down More Than 15% in a Year: Time to Buy, Sell or Hold?

Pharma Companies Remain Calm Amid Fresh Tariff Threat by Trump

Zacks

2 days ago

Pharma Companies Remain Calm Amid Fresh Tariff Threat by Trump

MT Newswires

2 days ago

Morgan Stanley Adjusts Price Target on Eli Lilly to $1,135 From $1,133, Maintains Overweight Rating

Big Pharma on the Clock as 200% Tariffs Loom

GuruFocus.com

2 days ago

Big Pharma on the Clock as 200% Tariffs Loom

3 Reasons I Bought Novo Nordisk Stock Instead of Eli Lilly

Motley Fool

2 days ago

3 Reasons I Bought Novo Nordisk Stock Instead of Eli Lilly

Eli Lilly (LLY) Beats Stock Market Upswing: What Investors Need to Know

Zacks

2 days ago

Eli Lilly (LLY) Beats Stock Market Upswing: What Investors Need to Know

MT Newswires

2 days ago

Sector Update: Health Care Stocks Higher Late Afternoon

MT Newswires

2 days ago

Sector Update: Health Care

Eli Lilly (NYSE:LLY) Gains FDA Approval For New Alzheimer's Drug Dosing Schedule

Simply Wall St.

2 days ago

Eli Lilly (NYSE:LLY) Gains FDA Approval For New Alzheimer's Drug Dosing Schedule

Is Novo Nordisk Increasing Dosage to Defend Wegovy's Edge in Obesity?

Zacks

3 days ago

Is Novo Nordisk Increasing Dosage to Defend Wegovy's Edge in Obesity?

Concentra Group Holdings (CON) Strengthens Board to Accelerate Growth

Insider Monkey

3 days ago

Concentra Group Holdings (CON) Strengthens Board to Accelerate Growth

Trump's Drug Tariffs: Where Does the U.S. Import Pharmaceuticals From?

The Wall Street Journal

3 days ago

Trump's Drug Tariffs: Where Does the U.S. Import Pharmaceuticals From?

MT Newswires

3 days ago

Eli Lilly Gets FDA Approval for Updated Kisunla Dosing for Alzheimer's

FDA approves updated label for Lilly's Kisunla (donanemab-azbt) with new dosing in early symptomatic Alzheimer's disease

PR Newswire

3 days ago

FDA approves updated label for Lilly's Kisunla (donanemab-azbt) with new dosing in early symptomatic Alzheimer's disease

Stocks to Watch Wednesday: Freeport-McMoRan, UnitedHealth, Novo Nordisk

The Wall Street Journal

3 days ago

Stocks to Watch Wednesday: Freeport-McMoRan, UnitedHealth, Novo Nordisk

Alcohol Use Disorder Market Report 2025-2035 Featuring Clearmind Medicine, Purdue Pharma, Psyence Biomedical, Eli Lilly and Co, Tempero Bio,, Nxera Pharma, Novo Nordisk, Adial, Alkermes, Lundbeck

GlobeNewswire

3 days ago

Alcohol Use Disorder Market Report 2025-2035 Featuring Clearmind Medicine, Purdue Pharma, Psyence Biomedical, Eli Lilly and Co, Tempero Bio,, Nxera Pharma, Novo Nordisk, Adial, Alkermes, Lundbeck

Eli Lilly (LLY) Announced Results for its Once-Weekly Insulin

Insider Monkey

3 days ago

Eli Lilly (LLY) Announced Results for its Once-Weekly Insulin

Regeneron’s Blockbuster Dupixent Faces a New Rival

Barrons.com

3 days ago

Regeneron’s Blockbuster Dupixent Faces a New Rival

Schizophrenia Market Research and Forecast Report 2025-2034 | Emerging Therapies and Genetic Research Drive Growth with Bristol Myers Squibb, AstraZeneca, and Eli Lilly Leading

GlobeNewswire

4 days ago

Schizophrenia Market Research and Forecast Report 2025-2034 | Emerging Therapies and Genetic Research Drive Growth with Bristol Myers Squibb, AstraZeneca, and Eli Lilly Leading

Anti-Obesity Drugs Market Research and Forecast Report 2025 | Market to Surpass $120 Billion by 2034 - Increased Strategic Merger and Initiatives to Meet Rising Demand

GlobeNewswire

4 days ago

Anti-Obesity Drugs Market Research and Forecast Report 2025 | Market to Surpass $120 Billion by 2034 - Increased Strategic Merger and Initiatives to Meet Rising Demand

Analysis: 'Trump Effect' website takes credit for US investment made under Biden

Reuters

4 days ago

Analysis: 'Trump Effect' website takes credit for US investment made under Biden

3 Underrated Dividend Growth Stocks to Buy and Hold for Years

Motley Fool

4 days ago

3 Underrated Dividend Growth Stocks to Buy and Hold for Years

Apogee Dives. But It Could Eventually Rival Sanofi's Biggest Moneymaker.

Investor's Business Daily

4 days ago

Apogee Dives. But It Could Eventually Rival Sanofi's Biggest Moneymaker.

MT Newswires

4 days ago

Sector Update: Health Care

Investing.com

4 days ago

Prime Medicine stock soars amid gene editing sector momentum

Queens Harbour: The New Heartbeat of Toronto's Waterfront

CNW Group

5 days ago

Queens Harbour: The New Heartbeat of Toronto's Waterfront

Novo and Lilly compete in India as obesity drugs demand hikes

Reuters Videos

5 days ago

Novo and Lilly compete in India as obesity drugs demand hikes

Summer gas prices are headed even lower, as Saudi Arabia accepts the 'lesser evil' of cheap oil

Business Insider

5 days ago

Summer gas prices are headed even lower, as Saudi Arabia accepts the 'lesser evil' of cheap oil

Total Energy Services Inc. Announces 2025 Second Quarter Conference Call and Webcast

GlobeNewswire

5 days ago

Total Energy Services Inc. Announces 2025 Second Quarter Conference Call and Webcast

Almonty Announces Application to List on Nasdaq Capital Market Concurrent with Launch of U.S. Public Offering

Business Wire

5 days ago

Almonty Announces Application to List on Nasdaq Capital Market Concurrent with Launch of U.S. Public Offering

Bira 91 re-enters Uttar Pradesh through new manufacturing partnership

Just Drinks

5 days ago

Bira 91 re-enters Uttar Pradesh through new manufacturing partnership

China’s Feihe issues profit warning

Just Food

5 days ago

China’s Feihe issues profit warning

India’s Vintage Coffee and Beverages to raise funds for new plant

Just Drinks

5 days ago

India’s Vintage Coffee and Beverages to raise funds for new plant

Investing.com

5 days ago

Who could win and lose on tighter Trump AI controls? UBS weighs in

2 Dividend Growth Stocks to Buy and Hold Forever

Motley Fool

6 days ago

2 Dividend Growth Stocks to Buy and Hold Forever

Will Novo Nordisk's Rare Disease Bets Reduce GLP-1 Reliance?

Zacks

8 days ago

Will Novo Nordisk's Rare Disease Bets Reduce GLP-1 Reliance?

UBS Sees Strong Sales Outlook for Eli Lilly’s Zepbound and Mounjaro

Insider Monkey

8 days ago

UBS Sees Strong Sales Outlook for Eli Lilly’s Zepbound and Mounjaro

Lilly and Novo Are the Kings of Weight-Loss Drugs. The Companies Coming for Their Crowns.

Barrons.com

8 days ago

Lilly and Novo Are the Kings of Weight-Loss Drugs. The Companies Coming for Their Crowns.

Novo Nordisk Ignored Internal Warnings On Wegovy Launch Preparedness: Report

Benzinga

8 days ago

Novo Nordisk Ignored Internal Warnings On Wegovy Launch Preparedness: Report

Eli Lilly (LLY) Staring at Tremendous Opportunity in Alzheimer Market: RBC Capital Markets

Insider Monkey

9 days ago

Eli Lilly (LLY) Staring at Tremendous Opportunity in Alzheimer Market: RBC Capital Markets

Pfizer Trades Above 50-Day Average for a Month: Time to Buy?

Zacks

9 days ago

Pfizer Trades Above 50-Day Average for a Month: Time to Buy?

Here's How Lilly's Non-Obesity Drugs are Contributing to Sales Growth

Zacks

9 days ago

Here's How Lilly's Non-Obesity Drugs are Contributing to Sales Growth

Wall Street Bulls Look Optimistic About Lilly (LLY): Should You Buy?

Zacks

10 days ago

Wall Street Bulls Look Optimistic About Lilly (LLY): Should You Buy?

Will AbbVie's Acquisition Spree Aid Pipeline Growth?

Zacks

10 days ago

Will AbbVie's Acquisition Spree Aid Pipeline Growth?

Semaglutide Market Forecast Report 2025-2033 | Growth Accelerates Amid Rising Awareness, Regulatory Approvals, and Strong Pipeline Advancements

GlobeNewswire

10 days ago

Semaglutide Market Forecast Report 2025-2033 | Growth Accelerates Amid Rising Awareness, Regulatory Approvals, and Strong Pipeline Advancements

2 Growth Stocks to Buy Hand Over Fist in July

Motley Fool

10 days ago

2 Growth Stocks to Buy Hand Over Fist in July

This GLP-1 Stock's Bad News Could Be a Big Win for Eli Lilly and Novo Nordisk

Motley Fool

10 days ago

This GLP-1 Stock's Bad News Could Be a Big Win for Eli Lilly and Novo Nordisk

MT Newswires

11 days ago

Update: Market Chatter: Novo Nordisk Executives Ignored Warnings Against Wegovy Launch

Here is What to Know Beyond Why Eli Lilly and Company (LLY) is a Trending Stock

Zacks

11 days ago

Here is What to Know Beyond Why Eli Lilly and Company (LLY) is a Trending Stock

MT Newswires

11 days ago

Market Chatter: Novo Nordisk Executives Ignored Warnings Against Wegovy Launch

Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?

Zacks

11 days ago

Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?

Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?

Zacks

11 days ago

Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?

How Novo Nordisk misread the US market for its weight loss sensation

Reuters

11 days ago

How Novo Nordisk misread the US market for its weight loss sensation

FDA Approves Updated Label For Eli Lilly and Company (LLY)’s Amyvid To Support Alzheimer’s Diagnosis

Insider Monkey

11 days ago

FDA Approves Updated Label For Eli Lilly and Company (LLY)’s Amyvid To Support Alzheimer’s Diagnosis

Can Protagonist Take On Eli Lilly's Next-Generation Obesity Treatment?

Investor's Business Daily

11 days ago

Can Protagonist Take On Eli Lilly's Next-Generation Obesity Treatment?

Eli Lilly (LLY) Faces Bearish Options Flow, But Probabilities Tell a Different Story

Barchart

11 days ago

Eli Lilly (LLY) Faces Bearish Options Flow, But Probabilities Tell a Different Story

Will CVS Health's Formulary Move Boost Its Weight Management Program? (Revised)

Zacks

12 days ago

Will CVS Health's Formulary Move Boost Its Weight Management Program? (Revised)

Which Stock Will Dominate the Weight Management Market Through 2030?

Motley Fool

14 days ago

Which Stock Will Dominate the Weight Management Market Through 2030?

Truist Reiterates Eli Lilly (LLY) Buy Rating on Orforglipron Diabetes Drug Data

Insider Monkey

14 days ago

Truist Reiterates Eli Lilly (LLY) Buy Rating on Orforglipron Diabetes Drug Data

Citi Expresses Optimism for Eli Lilly and Company (LLY)

Insider Monkey

14 days ago

Citi Expresses Optimism for Eli Lilly and Company (LLY)

NVO vs. LLY: Which Obesity Powerhouse is the Stronger Bet Now?

Zacks

15 days ago

NVO vs. LLY: Which Obesity Powerhouse is the Stronger Bet Now?

Amgen Looks to Take Share of Booming Obesity Space: Will It Succeed?

Zacks

15 days ago

Amgen Looks to Take Share of Booming Obesity Space: Will It Succeed?

MT Newswires

15 days ago

Eli Lilly 'Clear Leader in Obesity' Drugs, UBS Says; Raises 2025 Earnings Forecast

AbbVie Adds More Than $24B in 6 Months: How to Play ABBV Stock

Zacks

15 days ago

AbbVie Adds More Than $24B in 6 Months: How to Play ABBV Stock

Investing.com

15 days ago

BMO downgrades Verve Therapeutics saying Lilly buyout deal caps upside

Eli Lilly receives FDA approval for Amyvid label update

Pharmaceutical Technology

16 days ago

Eli Lilly receives FDA approval for Amyvid label update

5 Revealing Analyst Questions From Eli Lilly’s Q1 Earnings Call

StockStory

16 days ago

5 Revealing Analyst Questions From Eli Lilly’s Q1 Earnings Call

Why Viking Therapeutics, 67% Off Its Recent Highs, Could Still Have An Edge In Obesity

Investor's Business Daily

16 days ago

Why Viking Therapeutics, 67% Off Its Recent Highs, Could Still Have An Edge In Obesity

Eli Lilly and Company (LLY) Is Going To Be A “Trillion-Dollar Market Cap,” Says Jim Cramer

Insider Monkey

17 days ago

Eli Lilly and Company (LLY) Is Going To Be A “Trillion-Dollar Market Cap,” Says Jim Cramer

Novo Nordisk A/S (NVO): “How Could They Be So Far Behind?,” Wonders Jim Cramer

Insider Monkey

17 days ago

Novo Nordisk A/S (NVO): “How Could They Be So Far Behind?,” Wonders Jim Cramer

NKTR Stock Soars as Lead Drug Meets Goal in Atopic Dermatitis Study

Zacks

17 days ago

NKTR Stock Soars as Lead Drug Meets Goal in Atopic Dermatitis Study

Novo Nordisk split puts Hims & Hers future in question

Yahoo Finance

17 days ago

Novo Nordisk split puts Hims & Hers future in question

Investing.com

17 days ago

Citi bullish on Lilly as Orforglipron unlocks $40B+ obesity market

3 Reasons to Buy Eli Lilly Stock Like There's No Tomorrow

Motley Fool

17 days ago

3 Reasons to Buy Eli Lilly Stock Like There's No Tomorrow

United States Insulin Pens Market Research Report 2025-2033, Advances in Technology, Favorable Reimbursement Policies, Increasing Awareness and Adoption

GlobeNewswire

17 days ago

United States Insulin Pens Market Research Report 2025-2033, Advances in Technology, Favorable Reimbursement Policies, Increasing Awareness and Adoption

Eli Lilly Mounjaro Sees Strong Reception in India, Rising Demand Amid Obesity, Diabetes Rates

Insider Monkey

17 days ago

Eli Lilly Mounjaro Sees Strong Reception in India, Rising Demand Amid Obesity, Diabetes Rates

Essential Pharma strengthens Board with the appointment of Nicola Heffron as Non-Executive Director

GlobeNewswire

17 days ago

Essential Pharma strengthens Board with the appointment of Nicola Heffron as Non-Executive Director

The Weight Loss Drug Market Has Gotten Messy. What to Know.

Barrons.com

17 days ago

The Weight Loss Drug Market Has Gotten Messy. What to Know.

Hims & Hers Strengthens Its Footprint in Consumer-Driven Obesity Care

Zacks

18 days ago

Hims & Hers Strengthens Its Footprint in Consumer-Driven Obesity Care

Eli Lilly (LLY) Retains $1,100 Price Target at Bernstein Ahead of Diabetes Conference

Insider Monkey

18 days ago

Eli Lilly (LLY) Retains $1,100 Price Target at Bernstein Ahead of Diabetes Conference

Novo Nordisk Backs Away From Hims & Hers Partnership

The Daily Upside

18 days ago

Novo Nordisk Backs Away From Hims & Hers Partnership

Eli Lilly (LLY) Surpasses Market Returns: Some Facts Worth Knowing

Zacks

18 days ago

Eli Lilly (LLY) Surpasses Market Returns: Some Facts Worth Knowing

Novo Nordisk Stock Drops on Weight-Loss Data. Why Investors Have Doubts.

Barrons.com

18 days ago

Novo Nordisk Stock Drops on Weight-Loss Data. Why Investors Have Doubts.

Amgen Shares Fall on Weight-Loss Drug Tummy Troubles

Barrons.com

18 days ago

Amgen Shares Fall on Weight-Loss Drug Tummy Troubles

HIMS Stock Crashes 30% in a Day: Time to Buy the Dip?

Zacks

18 days ago

HIMS Stock Crashes 30% in a Day: Time to Buy the Dip?

Novo–Hims & Hers deal ends, Eli Lilly GLP-1 pill: What to know

Yahoo Finance Video

19 days ago

Novo–Hims & Hers deal ends, Eli Lilly GLP-1 pill: What to know

Eli Lilly seeks green light for weekly insulin after strong trial results

Clinical Trials Arena

19 days ago

Eli Lilly seeks green light for weekly insulin after strong trial results

Lilly expects orforglipron obesity results in third quarter

Reuters

21 days ago

Lilly expects orforglipron obesity results in third quarter

PR Newswire

21 days ago

Lilly's oral GLP-1, orforglipron, showed compelling efficacy and a safety profile consistent with injectable GLP-1 medicines, in complete Phase 3 results published in The New England Journal of Medicine

MT Newswires

21 days ago

S&P 500 Edges Down Weekly as Declines Led by Health Care Outweigh Energy-Led Gains

MT Newswires

21 days ago

Sector Update: Health Care Stocks Retreat Late Afternoon

Muscle-preserving drugs could generate over $30 billion in sales by 2035, TD Cowen says

Reuters

21 days ago

Muscle-preserving drugs could generate over $30 billion in sales by 2035, TD Cowen says

A $1.3 Billion Reason to Buy Eli Lilly Stock Now

Barchart

21 days ago

A $1.3 Billion Reason to Buy Eli Lilly Stock Now

MT Newswires

21 days ago

Sector Update: Health Care Stocks Softer in Afternoon Trading

MT Newswires

21 days ago

Sector Update: Health Care

Share on Social Networks: